<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<style>
body{font-family:Helvetica,Arial,sans-serif;max-width:700px;margin:40px auto;padding:20px;line-height:1.6;color:#1a1a1a}
h1{color:#dc2626;border-bottom:2px solid #dc2626;padding-bottom:10px}
h2{color:#1e40af;margin-top:30px}
h3{color:#374151;margin-top:20px}
table{border-collapse:collapse;width:100%;margin:15px 0}
th,td{border:1px solid #d1d5db;padding:8px 12px;text-align:left}
th{background:#f3f4f6}
hr{border:none;border-top:1px solid #e5e7eb;margin:30px 0}
a{color:#dc2626}
strong{color:#111827}
code{background:#f3f4f6;padding:2px 6px;border-radius:4px}
blockquote{border-left:3px solid #dc2626;padding-left:15px;margin:15px 0;color:#4b5563}
</style>
</head>
<body>
<h1>‚òÄÔ∏è Morning Brief ‚Äî February 4, 2026</h1>
<p><strong>Prepared for Dr. Peter Bleszynski, MD, FACC, FSCAI</strong></p>
<hr>

<h2>ü´Ä STRUCTURAL HEART</h2>

<h3>1. 3D Intracardiac Echocardiography in Structural Heart Interventions</h3>
<p><strong>Expert Review | EuroIntervention | February 4, 2026</strong><br>
<strong>Authors:</strong> Sergio Berti, Ralph Stephan von Bardeleben, et al.<br>
<strong>Link:</strong> <a href="https://eurointervention.pcronline.com/article/three-dimensional-intracardiac-echocardiography-in-structural-heart-disease-interventions">Full Text (Free)</a></p>

<p><strong>Summary:</strong> Comprehensive expert review establishing standardized protocols for 3D ICE use across structural heart interventions. 3D ICE is emerging as a powerful alternative to TEE, allowing procedures under local anesthesia only.</p>

<p><strong>Key Points:</strong></p>
<ul>
<li>TEE-free procedures now possible for LAAO, PFO closure, and mitral ViV</li>
<li>ICE provides superior tricuspid visualization vs. far-field TEE views</li>
<li>Procedures covered: TAVR, LAAO, PFO/ASD closure, M-TEER, T-TEER, TTVR</li>
</ul>

<blockquote>üíé <strong>Clinical Pearl:</strong> With your PFO/ASD closure volume, this review offers standardized ICE positioning protocols that could streamline workflow.</blockquote>

<hr>

<h3>2. DurAVR Biomimetic THV: 30-Day Outcomes in Small Aortic Annuli</h3>
<p><strong>Original Research | Open Access | EuroIntervention | February 2, 2026</strong><br>
<strong>Authors:</strong> Ole De Backer, Vinayak N. Bapat, et al.<br>
<strong>Link:</strong> <a href="https://eurointervention.pcronline.com/article/thirty-day-outcomes-of-a-novel-biomimetic-balloon-expandable-transcatheter-heart-valve-in-patients-with-small-aortic-annuli">Full Text (Open Access)</a></p>

<p><strong>Summary:</strong> Novel balloon-expandable valve with single-piece biomimetic leaflet design. Pooled analysis from EMBARK FIH and Early Feasibility Studies (n=100).</p>

<table>
<tr><th>Metric</th><th>Result</th></tr>
<tr><td>Technical Success</td><td>93%</td></tr>
<tr><td>30-Day Mortality</td><td>0%</td></tr>
<tr><td>Mean Gradient</td><td>8.2 mmHg</td></tr>
<tr><td>EOA</td><td>2.2 cm¬≤</td></tr>
<tr><td>Moderate+ PPM</td><td>3%</td></tr>
<tr><td>New PPI Rate</td><td>6%</td></tr>
</table>

<p><strong>Population:</strong> Mean age 77, 78% female, STS 4.7%, annulus area 404¬±37 mm¬≤</p>

<blockquote>üíé <strong>Clinical Pearl:</strong> Impressive numbers for small annulus. The 3% moderate+ PPM rate is excellent. Watch for durability data.</blockquote>

<hr>

<h3>3. Residual Mean Gradient After TAVI Predicts Long-Term SVD</h3>
<p><strong>Original Research | EuroIntervention | January 26, 2026</strong><br>
<strong>Authors:</strong> Palmerini T, Saia F, Gali√® N, et al. (12 Italian centers)<br>
<strong>Link:</strong> <a href="https://eurointervention.pcronline.com/article/predictors-of-long-term-structural-valve-deterioration-and-failure-after-transcatheter-aortic-valve-implantation">Full Text</a></p>

<p><strong>Key Findings:</strong></p>
<ul>
<li>Early residual MPG independently predicts structural valve deterioration</li>
<li>SVD associated with high rates of bioprosthetic valve failure</li>
<li>Increased 10-year all-cause mortality with elevated post-procedural gradients</li>
</ul>

<blockquote>üíé <strong>Clinical Pearl:</strong> Don't accept suboptimal hemodynamics at implant. What happens in the cath lab matters long-term.</blockquote>

<hr>

<h2>‚ö° QUICK HITS</h2>

<p><strong>M-TEER + GDMT Superiority Confirmed</strong> ‚Äî Meta-analysis of MITRA-FR + COAPT + RESHAPE-HF2 (n=1,422). TEER + GDMT reduced death/HF hospitalization at 24 months (HR 0.72).</p>

<p><strong>AF Common After PFO Closure</strong> ‚Äî 19.3% developed AF at 30 days, 27.6% at 1 year despite pre-closure ICM screening. 25% occurred beyond 30 days. Device-induced late AF may be real.</p>

<p><strong>Small Annulus TAVR: BEV vs SEV Meta-Analysis</strong> ‚Äî Critical for device selection in challenging anatomy.</p>

<hr>

<h2>üì± #CardioTwitter Trends</h2>
<ul>
<li>3D ICE adoption debate: When does ICE fully replace TEE?</li>
<li>DurAVR interest: "Finally a valve designed for small annulus"</li>
<li>Gradient discussion: Editorial sparking debate on acceptable thresholds</li>
</ul>

<hr>
<p style="text-align:center;color:#6b7280;font-size:14px">Sources: EuroIntervention, PubMed<br>Compiled by Vienna | February 4, 2026</p>
</body>
</html>
